Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SoFi Announces Monthly Distributions on $THTA (10.00%)
-
Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update
-
GraniteShares Announces Weekly Distributions for its YieldBOOST FoFs ETFs: YBST and YBTY
-
Foremost Clean Energy Grants Stock Options
-
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
-
CSPi Reports FY2026 Third Quarter Results
-
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
-
GT Biopharma Reports Second Quarter 2026 Financial Results
-
Dycom Industries, Inc. to Host Fiscal 2027 Second Quarter Results Call on August 26, 2026
-
Associa Earns 2026 Great Place to Work Certification™
-
Chair of AB KN Energies Audit Committee Elected
-
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
-
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
-
Prosafe SE: Invitation to webcast on Q2 and first half 2026 results on 28 August 2026
-
LanzaTech Reports Second Quarter 2026 Financial Results
-
SurgePays Reports Q2 2026 Revenue Growth of 40.7% Year-Over-Year to $16.2 Million, Reports Positive Net Income of $1.29 Million
-
Beneficient Reports First Quarter Fiscal 2027 Results
-
Edible Garden Reports Second Quarter 2026 Results; Revenue Grows 12.8%, Sales Increase 31.2% as Company Accelerates Farm-to-Formula® Strategy
-
WRAP Selected by WOFT to Support Florida’s $475,000 Teacher Safety Training Initiative
-
Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks
-
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
-
Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance
-
Milestone Scientific Reports Financial Results for Second Quarter 2026
-
Base Carbon Reports Second-Quarter 2026 Operating and Financial Results
-
Applied Materials to Participate in Upcoming Investor Conferences
-
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
-
Investeringsforeningen ValueInvest Danmark – Indkaldelse til ekstraordinær generalforsamling
-
36th Qingdao Int'l Beer Festival Ignites Summer Tourism Vitality
-
36th Qingdao Int'l Beer Festival Ignites Summer Tourism Vitality
-
Investeringsforeningen ValueInvest Danmark – Halvårsrapport 2026
-
ProVen Growth and Income VCT plc: Director/PDMR Shareholding
-
Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™
-
ProVen Growth and Income VCT plc: Issue of Equity
-
ProVen VCT plc: Director/PDMR Shareholding
-
ProVen VCT plc: Issue of Equity
-
Saputo Enters Agreement to Sell its United Kingdom Operations
-
A free, AI-powered youth entrepreneurship platform, “Dear Dreamer,” launches, built at the Martin Trust Center for MIT Entrepreneurship and made possible through a gift by the Frank & Eileen F
-
A free, AI-powered youth entrepreneurship platform, “Dear Dreamer,” launches, built at the Martin Trust Center for MIT Entrepreneurship and made possible through a gift by the Frank & Eileen Found
-
Koryx Copper Provides Further Drill Results for the Haib Copper Project in Southern Namibia
-
Almaden Provides Update on Arbitration Process with Mexico
-
Prospectiva Resources Begins Trading on the TSX Venture Exchange
-
J & J SNACK FOODS CORP. ANNOUNCES QUARTERLY CASH DIVIDEND
-
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
-
Kanen Wealth Management calls for sale of Zevia to Maximize shareholder value
-
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
Aurora Mobile and Exabytes Sign Three-Year Strategic MoU to Bring AI-Powered Customer Engagement to Businesses Across Southeast Asia
-
J & J SNACK FOODS CORP. ANNOUNCES QUARTERLY CASH DIVIDEND
-
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences
-
Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis
-
Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress
